摘要
目的观察分析贝那普利和阿托伐他汀联用对2型糖尿病并发肾病临床治疗效果的影响。方法选择我院2013年4月-2015年3月收治的88例糖尿病肾病（DN）患者,随机分为联合组和对照组,每组44例,对照组采用贝那普利治疗,联合组联合应用阿托伐他汀治疗,比较两组治疗前后TC、TG、UAER、Scr以及BUN水平。结果治疗后,两组TC、TG、UAER、Scr以及BUN水平均得到改善,联合组改善较对照组好,差异均有统计学意义（P〈0.05）。结论贝那普利和阿托伐他汀联用治疗DN可以改善患者血脂代谢以及肾功能,治疗效果比较理想。
Objective Observation and analysis the clinical effects of benazepril and atorvastatin in type 2 diabetes mellitus complicated with nephropathy. Methods Admitted to our hospital from April 2013 to March 2015,88 cases of diabetic nephropathy（DN）were randomly divided into the combined group and control group,44 patients in each group,the control group treated with benazepril,combined set of combined application of atorvastatin in the treatment and compared between the two groups before and after treatment,TC,TG,and UAER,Scr and BUN levels. Results After treatment,both groups TC,TG,UAER,Scr and BUN levels are significantly improved,the combined group to improve more significantly than the control group,there were significant differences（P〈0.05）. Conclusion Benazepril and atorvastatin in the treatment of DN can significantly improve lipid metabolism and renal function,the curative effect is ideal.
出处
《中国卫生标准管理》
2016年第5期96-97,共2页
China Health Standard Management
